ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Candel Therapeutics Inc

Candel Therapeutics Inc (CADL)

0,00
0,00
(0,00%)
Geschlossen 22 Januar 10:00PM
0,00
0,00
(0,00%)
Nach Börsenschluss: -

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
-
Gebot
-
Fragen
-
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
-
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
32.475.537
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,66
Gewinn pro Aktie (EPS)
-1,17
Erlöse
-
Nettogewinn
-37,94M

Über Candel Therapeutics Inc

Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Candel Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CADL. The last closing price for Candel Therapeutics was -. Over the last year, Candel Therapeutics shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Candel Therapeutics currently has 32.475.537 shares in issue. Candel Therapeutics has a price to earnings ratio (PE ratio) of -5.66.

CADL Neueste Nachrichten

Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025

On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC), expected in Q1...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CADL - Frequently Asked Questions (FAQ)

What is the current Candel Therapeutics share price?
The current share price of Candel Therapeutics is US$ 0,00
How many Candel Therapeutics shares are in issue?
Candel Therapeutics has 32.475.537 shares in issue
What is the 1 year trading range for Candel Therapeutics share price?
Candel Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Candel Therapeutics?
The price to earnings ratio of Candel Therapeutics is -5,66
What is the reporting currency for Candel Therapeutics?
Candel Therapeutics reports financial results in USD
What is the latest annual profit for Candel Therapeutics?
The latest annual profit of Candel Therapeutics is USD -37,94M
What is the registered address of Candel Therapeutics?
The registered address for Candel Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Candel Therapeutics website address?
The website address for Candel Therapeutics is www.candeltx.com
Which industry sector does Candel Therapeutics operate in?
Candel Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ASSTAsset Entities Inc
US$ 0,8998
(93,71%)
263,47M
DWTXDogwood Therapeutics Inc
US$ 3,18
(70,05%)
24,31M
USEGUS Energy Corp
US$ 3,74
(61,21%)
107,79M
DOGZDogness International Corporation
US$ 27,62
(52,60%)
1,95M
MYNAMynaric AG
US$ 0,6697
(50,83%)
3,72M
GOEVCanoo Inc
US$ 0,3748
(-72,24%)
41,46M
SHOTWSafety Shot Inc
US$ 0,1094
(-47,40%)
18,66k
ORKTOrangeKloud Technology Inc
US$ 0,7068
(-36,89%)
7,67M
HEPAHepion Pharmaceuticals Inc
US$ 0,3219
(-31,36%)
1,66M
WNWMeiwu Technology Company Ltd
US$ 0,2681
(-27,05%)
11,12M
GCTKGlucoTrack Inc
US$ 0,1226
(44,41%)
613,28M
CRKNCrown Electrokinetics Corporation
US$ 0,1121
(-10,32%)
392,52M
ASSTAsset Entities Inc
US$ 0,8998
(93,71%)
262,98M
RIMEAlgorhythm Holdings Inc
US$ 0,034599
(-16,83%)
230,08M
RGTIRigetti Computing Inc
US$ 13,97
(42,12%)
226,81M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock